Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice GuidelineSaro H. Armenian, Daniel J. Lenihan, Bonnie Ky et al.|Journal of Clinical Oncology|2017Cited by 1.3k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Peter Valent, Daniel J. Lenihan et al.|European Heart Journal|2021Cited by 589
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupSaro H. Armenian, Leontien C.M. Kremer, Melissa M. Hudson et al.|The Lancet Oncology|2015Cited by 561
A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization GroupLeontien C.M. Kremer, Melissa M. Hudson, Renée L. Mulder et al.|Pediatric Blood & Cancer|2012Cited by 361
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group ReportSaro H. Armenian, Minoo Battiwalla, Wassim Chemaitilly et al.|Biology of Blood and Marrow Transplantation|2016Cited by 103